Pre-radiotherapy FDG PET predicts radiation pneumonitis in lung cancer

Radiation Oncology

Volumn 9, Issue 1, 2014, Pages

  Castillo, Richard ^b   Pham, Ngoc ^a   Ansari, Sobiya ^d,f   Meshkov, Dmitriy ^a   Castillo, Sarah ^d   Li, Min ^d   Olanrewaju, Adenike ^d   Hobbs, Brian ^c   Castillo, Edward ^d,e   Guerrero, Thomas ^a,d,e  

^a UNIVERSITY OF TEXAS   (United States)

^b Diagnostic Imaging   (United States)

^c Division of Quantitative Sciences   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e Rice University   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Imaging biomarker; NSCLC; PET CT; Radiation pneumonitis; Standard uptake value; Thoracic radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; ARTIFACT; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOSIMETRY; DRUG UPTAKE; FEMALE; HEART; HUMAN; IMAGE ANALYSIS; LIVER; LUNG; LUNG NON SMALL CELL CANCER; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROTON THERAPY; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RADIATION PNEUMONIA; RETROSPECTIVE STUDY; SYMPTOM; TREATMENT PLANNING;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIMODAL IMAGING; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIATION PNEUMONITIS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899151495     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-9-74     Document Type: Article

References (57)

1. Ghafoori P, Marks LB, Vujaskovic Z, Kelsey CR. Radiation-induced lung injury. Assessment, management, and prevention. Oncology (Williston Park) 2008, 22(1):37-47. discussion 52-3.
2. Roberts CM, Foulcher E, Zaunders JJ, Bryant DH, Freund J, Cairns D, Penny R, Morgan GW, Breit SN. Radiation pneumonitis: a possible lymphocyte-mediated hypersensitivity reaction. Ann Intern Med 1993, 118(9):696-700. 10.7326/0003-4819-118-9-199305010-00006, 8460855.
3. Taghian AG, Assaad SI, Niemierko A, Kuter I, Younger J, Schoenthaler R, Roche M, Powell SN. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 2001, 93(23):1806-11. 10.1093/jnci/93.23.1806, 11734597.
4. Hart J, McCurdy MR, Ezhil M, Wei W, Khan M, Luo D, Munden R, Johnson V, Guerrero T. Radiation pneumonitis: Correlation of Toxicity with the Pulmonary Metabolic Radiation Response. Int J Radiat Oncol Biol Phys 2008, 71(4):967-971. 10.1016/j.ijrobp.2008.04.002, 3696885, 18495373.
5. McCurdy M, Wazni M, Martinez J, McAleer M, Guerrero T. Exhaled nitric oxide predicts radiation pneumonitis in esophageal and lung cancer patients receiving thoracic radiation. Radiotherapy and Oncology 2011, 101:443-448. 10.1016/j.radonc.2011.08.035, 21981878.
6. Rodrigues G, Lock M, D'Souza D, Yu E, Van Dyk J. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer-a systematic review. Radiotherapy and Oncology 2004, 71(2):127-138. 10.1016/j.radonc.2004.02.015, 15110445.
7. Palma D, Senan S, Tsujino K, Barriger R, Rengan R, Moreno M, Bradley J, Kim T, Ramella S, Marks L, de Petris L, Stitt L, Rodrigues G. Predicting radiation pneumonitis after chemoradiation therapy for lung cancer: An international individual patient data meta-analysis. Int. J. Radiation Oncology Biol. Phys. 2013, 85(2):444-450.
8. Allen AM, Czerminska M, Janne PA, Sugarbaker DJ, Bueno R, Harris JR, Court L, Baldini EH. Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006, 65(3):640-5. 10.1016/j.ijrobp.2006.03.012, 16751058.
9. Kristensen CA, Nottrup TJ, Berthelsen AK, Kjaer-Kristoffersen F, Ravn J, Sorensen JB, Engelholm SA. Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma. Radiother Oncol 2009, 92(1):96-9. 10.1016/j.radonc.2009.03.011, 19364621.
10. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 2007, 69(2):350-7. 10.1016/j.ijrobp.2007.03.011, 17467922.
11. Wang JY, Chen KY, Wang JT, Chen JH, Lin JW, Wang HC, Lee LN, Yang PC. Outcome and prognostic factors for patients with non-small-cell lung cancer and severe radiation pneumonitis. International Journal of Radiation Oncology, Biology, Physics. 2002, 54(3):735-41.
12. Kocak Z, Borst GR, Zeng J, Zhou S, Hollis DR, Zhang J, Evans ES, Folz RJ, Wong T, Kahn D, Belderbos JS, Lebesque JV, Marks LB. Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis. Int J Radiat Oncol Biol Phys 2007, 67(1):178-186. 10.1016/j.ijrobp.2006.09.031, 1829491, 17189069.
13. Bradley J, Paulus R, Komaki R, Masters G, Forster K, Schild S, Bogart J, Garces Y, Narayan S, Kavadi V, Nedzi L, Michalski J, Johnson D, MacRae R, Curran W, Choy H. A randomized phase III comparison of standard-dose (60 Gy) versus high-dose (74 Gy) conformal chemoradiotherapy with or without cetuximab for stage III non-small cell lung cancer: Results on radiation dose in RTOG 0617. J Clin Oncol 2013, 31(supp):7501.
14. Graham MV, Purdy JA, Emami B, Harms W, Bosch W, Lockett MA, Perez CA. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 1999, 45(2):323-9. 10.1016/S0360-3016(99)00183-2, 10487552.
15. Claude L, Perol D, Ginestet C, Falchero L, Arpin D, Vincent M, Martel I, Hominal S, Cordier JF, Carrie C. A prospective study on radiation pneumonitis following conformal radiation therapy in non-small-cell lung cancer: clinical and dosimetric factors analysis. Radiother Oncol 2004, 71(2):175-81. 10.1016/j.radonc.2004.02.005, 15110451.
16. Rancati T, Ceresoli GL, Gagliardi G, Schipani S, Cattaneo GM. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 2003, 67(3):275-83. 10.1016/S0167-8140(03)00119-1, 12865175.
17. Guerrero T, Martinez J, McCurdy M, Wolski M, McAleer M. Elevation in exhaled nitric oxide predicts for radiation pneumonitis. Int. J. Radiation Oncology Biol. Phys. 2012, 82(2):981-988.
18. Makimoto T, Tsuchiya S, Hayakawa K, Saitoh R, Mori M. Risk factors for severe radiation pneumonitis in lung cancer. Japanese Journal of Clinical Oncology. 1999, 29(4):192-7. 10.1093/jjco/29.4.192, 10340042.
19. Sanuki N, Ono A, Komatsu E, Kamei N, Akamine S, Yamazaki T, Mizunoe S, Maeda T. Association of computed tomography-detected pulmonary interstitial changes with severe radiation pneumonitis for patients treated with thoracic radiotherapy. J. Radiat. Res. 2012, 53:110-116. 10.1269/jrr.110142, 22302051.
20. Yamashita H, Kobayashi-Shibata S, Terahara A, Okuma K, Haga A, Wakui R, Ohtomo K, Nakagawa K. Prescreening based on the presence of CT-scan abnormalities and biomarkers (KL-6 and SP-D) may reduce severe radiation pneumonitis after stereotactic radiotherapy 2010, Oncology: Radiation, 5(32).
21. Jones HA, Clark RJ, Rhodes CG, Schofield JB, Krausz T, Haslett C. In vivo measurement of neutrophil activity in experimental lung inflammation. Am J Respir Crit Care Med 1994, 149(6):1635-1639. 10.1164/ajrccm.149.6.7516252, 7516252.
22. Chen DL, Rosenbluth DB, Mintun MA, Schuster DP. FDG-PET imaging of pulmonary inflammation in healthy volunteers after airway instillation of endotoxin. J Appl Physiol 2006, 100(5):1602-1609. 10.1152/japplphysiol.01429.2005, 16424067.
23. Chen DL, Ferkol TW, Mintun MA, Pittman JE, Rosenbluth DB, Schuster DP. Quantifying pulmonary inflammation in cystic fibrosis with positron emission tomography. Am J Respir Crit Care Med 2006, 173(12):1363-1369. 10.1164/rccm.200506-934OC, 2662975, 16543553.
24. Petit S, van Elmpt W, Oberije C, Vegt E, Dingemans A, Lambin P, Dekker A, de Ruysscher D. Fluorodeoxyglucose uptake patterns in lung before radiotherapy identify areas more susceptible to radiation -induced lung toxicity in non-small-cell lung cancer patients. J. Radiation Oncology Biol. Phys 2011, 81(3):698-705.
25. Pan T, Mawlawi O, Nehmeh SA, Erdi YE, Luo D, Liu HH, Castillo R, Mohan R, Liao Z, Macapinlac HA. Attenuation Correction of PET Images with Respiration-Averaged CT Images in PET/CT. J Nucl Med 2005, 46(9):1481-1487.
26. Strauss LG, Conti PS. The applications of PET in clinical oncology. J Nucl Med 1991, 32(4):623-648.
27. Liao Z, Liu H, Komaki R. Target delineation for esophageal cancer. Journal of Women's Imaging 2003, 5(4):177-186.
28. Vedam SS, Keall PJ, Kini VR, Mostafavi H, Shukla HP, Mohan R. Acquiring a four-dimensional computed tomography dataset using an external respiratory signal. Phys Med Biol 2003, 48(1):45-62. 10.1088/0031-9155/48/1/304, 12564500.
29. Pan T, Lee TY, Rietzel E, Chen GT. 4D-CT imaging of a volume influenced by respiratory motion on multi-slice CT. Med Phys 2004, 31(2):333-40. 10.1118/1.1639993, 15000619.
30. Osman MM, Cohade C, Nakamoto Y, Wahl RL. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. European journal of nuclear medicine and molecular imaging 2003, 30(4):603-606. 10.1007/s00259-002-1024-x, 12536242.
31. Proschan MWM. Practical guidelines for multiplicity adjustment in clinical trials. Controlled Clinical Trials 2000, 21:527-539. 10.1016/S0197-2456(00)00106-9, 11146147.
32. Akaike H. A new look at the statistical model identification. IEEE T Automat Contr 1974, 19(6):716-723.
33. Nagelkerke NJD. A note on a general definition of the co efficient of determination. Biometrika 1991, 78:691-692.
34. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44(3):837-45. 10.2307/2531595, 3203132.
35. Youden WJ. Index for rating diagnostic tests. Cancer 1950, 3(1):32-35. 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3, 15405679.
36. Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees, Monterey, Calif 1984, U.S.A.: Wadsworth, Inc.
37. McCulloch C, Searle S, Neuhaus J, Generalized L, Models M, 2nd ed. Hoboken 2008, NJ: Wiley.
38. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986, 1(8476):307-10.
39. de Prost N, Tucci MR, Melo MFV. Assessment of Lung Inflammation With 18 F-FDG PET During Acute Lung Injury. American Journal of Roentgenology 2010, 195(2):292-300. 10.2214/AJR.10.4499, 3172046, 20651183.
40. Dehing-Oberije C, De Ruysscher D, van Baardwijk A, Yu S, Rao B, Lambin P. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiotherapy and Oncology 2009, 91:421-426. 10.1016/j.radonc.2008.12.002, 19147245.
41. Ettinger DS, Akerley W, Bepler G, Blum MG, Chang A, Cheney RT, Chirieac LR, D' Amico TA, Demmy TL, Ganti AKP, Govindan R, Grannis FW, Jahan T, Jahanzeb M, Johnson DH, Kessinger A, Komaki R, Kong F-M, Kris MG, Krug LM, Le Q-T, Lennes IT, Martins R, O' Malley J, Osarogiagbon RU, Otterson GA, Patel JD, Pisters KM, Reckamp K, Riely GJ. Non-small cell lung cancer. Journal of the National Comprehensive Cancer Network. JNCCN 2010, 8(7):740-801.
42. Fischer B, Lassen U, Mortensen J, Larsen S, Loft A, Bertelsen A, Ravn J, Clementsen P, Høgholm A, Larsen K, Rasmussen T, Keiding S, Dirksen A, Gerke O, Skov B, Steffensen I, Hansen H, Vilmann P, Jacobsen G, Backer V, Maltbaek N, Pedersen J, Madsen H, Nielsen H, Højgaard L. Preoperative Staging of Lung Cancer with Combined PET-CT. The New England journal of medicine 2009, 361(1):32-39. 10.1056/NEJMoa0900043, 19571281.
43. Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition). Chest 2007, 132(3_suppl):178S-201S. 10.1378/chest.07-1360, 17873168.
44. Mac Manus MP, Hicks RJ. The role of positron emission tomography/computed tomography in radiation therapy planning for patients with lung cancer. Seminars in nuclear medicine 2012, 42(5):308-319. 10.1053/j.semnuclmed.2012.04.003, 22840596.
45. Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, Chu K, McEwan AJ, Halperin R, Roa WH. Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer. Radiother Oncol 2004, 73(3):285-7. 10.1016/j.radonc.2004.07.033, 15588872.
46. Marks LB, Munley MT, Spencer DP, Sherouse GW, Bentel GC, Hoppenworth J, Chew M, Jaszczak RJ, Coleman RE, Prosnitz LR. Quantification of radiation-induced regional lung injury with perfusion imaging. Int J Radiat Oncol Biol Phys 1997, 38(2):399-409. 10.1016/S0360-3016(97)00013-8, 9226329.
47. Marks LB, Spencer DP, Bentel GC, Ray SK, Sherouse GW, Sontag MR, Coleman RE, Jaszczak RJ, Turkington TG, Tapson V. The utility of SPECT lung perfusion scans in minimizing and assessing the physiologic consequences of thoracic irradiation. Int J Radiat Oncol Biol Phys 1993, 26(4):659-68. 10.1016/0360-3016(93)90285-4, 8330998.
48. Vinogradskiy Y, Castillo R, Castillo E, Tucker S, Zhongxing L, Guerrero T, Martel M. Using 4DCT-Based Ventilation Imaging to Correlate Lung Dose and Function with Clinical Outcomes. J Radiat Oncol Biol Phys 2013, in press.
49. Hope AJ, Lindsay PE, El Naqa I, Alaly JR, Vicic M, Bradley JD, Deasy JO. Modeling radiation pneumonitis risk with clinical, dosimetric, and spatial parameters. Int J Radiat Oncol Biol Phys 2006, 65(1):112-124. 10.1016/j.ijrobp.2005.11.046, 16618575.
50. Bradley JD, Hope A, Naqa IE, Apte A, Lindsay PE, Bosch W, Matthews J, Sause W, Graham MV, Deasy JO. A nomogram to predict radiation pneumonitis, derived from a combined analysis of RTOG 9311 and institutional data. Int J Radiat Oncol Biol Phys 2007, 69:984-995.
51. McCurdy M, McAleer MF, Wei W, Ezhil M, Johnson V, Khan M, Baker J, Luo D, Ajani J, Guerrero T. Induction and Concurrent Taxanes Enhance both the Pulmonary Metabolic Radiation Response and the Radiation Pneumonitis Response in Patients with Esophagus Cancer. Int J Radiat Oncol Biol Phys 2010, 76(3):816-823. 10.1016/j.ijrobp.2009.02.059, 3696888, 19525073.
52. Khan A, McNally D, Tutschka PJ, Bilgrami S. Paclitaxel-induced acute bilateral pneumonitis. Ann Pharmacother 1997, 31(12):1471-1474.
53. Wong P, Leung AN, Berry GJ, Atkins KA, Montoya JG, Ruoss SJ, Stockdale FE. Paclitaxel-induced hypersensitivity pneumonitis: Radiographic and CT findings. Am J Roentgenol 2001, 176(3):718-720.
54. Schweitzer VG, Juillard GJF, Bajada CL, Parker RG. Radiation recall dermatitis and pneumonitis in a patient treated with paclitaxel. Cancer 1995, 76(6):1069-1072. 10.1002/1097-0142(19950915)76:6<1069::AID-CNCR2820760623>3.0.CO;2-7, 8625210.
55. Machtay M, Bae K, Movsas B, Paulus R, Gore EM, Komaki R, Albain K, Sause WT, Curran WJ. Higher Biologically Effective Dose of Radiotherapy Is Associated With Improved Outcomes for Locally Advanced Non-Small Cell Lung Carcinoma Treated With Chemoradiation: An Analysis of the Radiation Therapy Oncology Group. International Journal of Radiation Oncology*Biology*Physics 2012, 82(1):425-434.
56. Didierlaurent D, Ribes S, Caselles O, Jaudet C, Cazalet J-M, Batatia H, Courbon F. A new respiratory gating device to improve 4D PET/CT. Medical Physics 2013, 40(3):32501-1-32501-9.
57. Barr JT, Schumacher GE, Freeman S, LeMoine M, Bakst AW, Jones PW. American translation, modification, and validation of the St. George's Respiratory Questionnaire. Clin Ther 2000, 22(9):1121-1145.